Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Corporate Action-Board approves Dividend

Recommended the Dividend of Re.0.30 Paise (30%) per equity share of face value of Rs.1/-each for the financial year 2022-23
24-05-2023
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for 1.Approval Of Audited Financial Statements (Standalone & Consolidated) For The Fourth Quarter And Financial Year Ended 31St March, 2023. 2.Consider, Recommend Dividend If Any, For The Financial Year 2022-2023

SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve 1. The Audited Financial Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2023. 2.To consider, recommend dividend if any, for the financial year 2022-2023
17-05-2023
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Clarification On Price Movement

Clarification on Price Movement
26-04-2023
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Clarification sought from SMS Pharmaceuticals Ltd

The Exchange has sought clarification from SMS Pharmaceuticals Ltd on April 25, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
26-04-2023
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Certificate Under Regulation 40(9)&(10) Of SEBI (LODR) Regulations, 2015, For 31St March, 2023

Compliance Certificate under Regulation 40(9)&(10) of SEBI (LODR) Regulations, 2015, for 31st March, 2023
21-04-2023
Next Page
Close

Let's Open Free Demat Account